Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
European Commission Approves Merck’s KEYTRUDA® Plus Chemotherapy for Resectable NSCLC
Friday, March 29, 2024Merck known as MSD outside of the United States and Canada today announced that the European Commission has approved KEYTRUDA Mercks antiPD therapy in combination
FSD Pharma Signs the Agreement With iNGENu CRO To Conduct a Clinical Study To Assess the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults
Thursday, March 28, 2024FSD Pharma Inc a biopharmaceutical company dedicated to building a portfolio of
Zai Lab and Novocure: METIS Phase 3 Trial Shows Extension in Time to Intracranial Progression for NSCLC Brain Metastases
Thursday, March 28, 2024Zai Lab Limited partner Novocure today announced the phase METIS clinical trial met its primary endpoint demonstrating a statistically significant improvement
Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
Wednesday, March 27, 2024Serina Therapeutics a clinicalstage biotechnology company developing a pipeline of therapies for the treatment of Parkinsons Disease and other neurological diseases today announced the closing of its previously
Teva UK and Closed Loop Medicine Announce Strategic Partnership to Advance Development of Personalised Medicines
Wednesday, March 27, 2024Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicines
Syndax Announces FDA Priority Review of NDA for Revumenib for the Treatment of Relapsed/Refractory KMT2Ar Acute Leukemia
Wednesday, March 27, 2024Syndax Pharmaceuticals a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies today announced that the US Food
Apogee Therapeutics Initiates Phase 1 Trial of APG808 for COPD and Inflammatory Diseases
Tuesday, March 26, 2024Apogee Therapeutics Inc a clinicalstage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis COPD asthma and other inflammatory and immunology
FUJIFILM Diosynth Biotechnologies Expands Manufacturing Agreement with Argenx for Efgartigimod for the Treatment of Severe Autoimmune Diseases
Tuesday, March 26, 2024FUJIFILM Diosynth Biotechnologies a worldleading contract development and manufacturing organization for biologics vaccines advanced therapies
Novo Nordisk to Acquire Cardior Pharmaceuticals and Strengthen Pipeline in Cardiovascular Disease
Monday, March 25, 2024Novo Nordisk and Cardior Pharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to billion Euros including an upfront payment and additional payments if certain development
Gilead Sciences Announces Completion of Acquisition of CymaBay
Saturday, March 23, 2024Gilead Sciences Inc today announced the completion of the previously announced transaction to acquire CymaBay Therapeutics Inc for approximately billion in total equity value The addition of CymaBays investigational lead product
